INT52199

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.06
First Reported 1995
Last Reported 2001
Negated 1
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 1.69
Pain Relevance 0.07

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (IFNA2) extracellular region (IFNA2) cell-cell signaling (IFNA2)
IFNA2 (Homo sapiens)
Pain Link Frequency Relevance Heat
local anesthetic 1 72.32 Quite High
depression 2 36.16 Quite Low
palliative 1 25.00 Low Low
Disease Link Frequency Relevance Heat
Lung Cancer 10 99.84 Very High Very High Very High
Cancer 4 99.56 Very High Very High Very High
Malignant Neoplastic Disease 3 97.86 Very High Very High Very High
Immunization 2 96.00 Very High Very High Very High
Thrombosis Related Under Development 1 94.56 High High
Weight Loss 1 93.80 High High
Fever 1 93.28 High High
Cytomegalovirus Infection 5 75.00 Quite High
Appetite Loss 1 45.76 Quite Low
Irritable Bowel Syndrome /

Irritable Bowel Syndrome Super

1 44.96 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A murine model of malignant mesothelioma was therefore used to examine the potential role of IL-6 in this cancer type and whether the effect of interferon alpha (IFN alpha) therapy on mesothelioma might be mediated, in part, by regulating IL-6 levels and/or IL-6-induced pathobiology.
Regulation (effect) of Gene_expression (therapy) of IFN alpha associated with malignant neoplastic disease, lung cancer and cancer
1) Confidence 0.06 Published 1995 Journal Cancer Immunol. Immunother. Section Abstract Doc Link 7750122 Disease Relevance 1.25 Pain Relevance 0
Co-expression of IFN-alpha did not affect the number of responding mice.
Neg (not) Regulation (affect) of Gene_expression (Co-expression) of IFN-alpha
2) Confidence 0.03 Published 2001 Journal Vaccine Section Abstract Doc Link 11427273 Disease Relevance 0.45 Pain Relevance 0.07

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox